Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 81,526 shares at $12.35 ($1.0M) on 2018-02-07, disclosed to the SEC on 2018-02-09.
Open-market sale of $1.0M CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.35 | 40,763 | $503K | 50.0% |
| 2 | $12.35 | 40,763 | $503K | 50.0% |
| Total | $12.35 avg | 81,526 | $1.0M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |